drugset
drugset / Trial / NCT07528651

Effects of S-ketamine on Perioperative Opioid Consumption

NCT07528651 ↗

Completed 53 enrolled Erasme University Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

This study is a triple-blind randomized controlled trial conducted at a tertiary care hospital in Brussels. It investigates whether a single dose of S-ketamine can reduce opioid (morphine) consumption in the first 24 hours after elective laparoscopic gynecological surgery in relatively healthy adult patients (ASA 1-2). The goal is to assess S-ketamine's effectiveness within a standardized postoperative pain management protocol.

Timeline

Start
2021-06-07
Primary completion
2022-06-21
Completion
2022-06-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Esketamine Other / unclassified 0.3 mg/kg Intravenous

Indications

No indication recorded.